Global Health & Biotech Archives | Page 17 of 286 | Be Korea-savvy

Archive by category Global Health & Biotech

Kalsec® Inc. Enhances and Rebrands Hops Division to KalHops

Kalsec® Inc. Enhances and Rebrands Hops Division to KalHops

Rebrand empowers brewers to “Brew Extraordinary™” with innovative and tailored hops offerings   KALAMAZOO, Mich., July 23, 2025 (Korea Bizwire) – Kalsec® Inc., a global natural ingredient solution provider for the food and beverage industry, today announced the relaunch of its hops division under the brand name KalHops. This strategic rebranding affirms Kalsec’s commitment to continued innovation [...]

Carestream Secures Partnership with Leading Distributor in Vietnam

Carestream Secures Partnership with Leading Distributor in Vietnam

ROCHESTER, N.Y., July 22, 2025 (Korea Bizwire) – Carestream Health recently secured an agreement with Vietnam South East Asia Joint Stock Company (VISTACOM), a leading distributor of advanced medical equipment solutions in Vietnam. “We are honored to join into a partnership with a renowned, industry leader like Carestream,” said Mr. Long Nguyen, Business Director of [...]

Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin

Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin

WASHINGTON, July 21, 2025 (Korea Bizwire) — Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and implementing immunization programs and strengthening health systems, joins the Sabin Vaccine Institute today as President of Global Immunization, assuming the reins of the nonprofit’s efforts in vaccination innovation and extending vaccine access. Martin [...]

Shadow Report Urges WHO FCTC to Embrace Tobacco Harm Reduction as a Core Strategy

Shadow Report Urges WHO FCTC to Embrace Tobacco Harm Reduction as a Core Strategy

MANILA, Philippines, July 21, 2025 (Korea Bizwire) – A newly revised Shadow Report, released by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), calls for a fundamental shift in the World Health Organization’s (WHO) approach to global tobacco control. The report criticizes the continued neglect of harm reduction under the WHO Framework Convention on [...]

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Company to participate in investor conferences in July and August VANCOUVER, British Columbia, July 17, 2025 (Korea Bizwire) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will [...]

EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology

EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology

ZURICH, July 17, 2025 (Korea Bizwire) — With over 7,600 delegates in attendance, EAACI Congress 2025 made headlines not just for its scale but for the powerful message delivered by its leadership. Now, one month after the Congress concluded in Glasgow, EAACI’s top figures are sharing their reflections on what they call a turning point [...]

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial

AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutation CELESTE is informed by the STELLA prospective natural history study, which is currently enrolling patients in the United States and Europe AAVB-039 uses AAVantgarde’s proprietary dual AAV intein platform. The platform has achieved [...]

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause

WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause

With renewed financial strength, WeightWatchers accelerates its transformation with the appointment of key executives including Dr. Kim Boyd as Chief Medical Officer The Company is advancing its first integrated women’s health initiative focused on perimenopause and menopause, combining medical, nutritional, lifestyle, and community-based support WeightWatchers successfully relists as a public company on Nasdaq under ticker [...]

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle.  Building on the long-standing success and performance of the best-in-class anchor fixation strength of the Q-FIX Family versus competitive devices*, the new [...]

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema

Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision in people with diabetic macular edema (DME).1 DME is a leading cause of vision loss in people [...]